— Know what they know.
Not Investment Advice
Also trades as: JUPWW (NASDAQ) · $vol 0M

JUPW NASDAQ

Jupiter Wellness, Inc.
1W: +10.1% 1M: -13.8% 3M: +178.7% 1Y: +70.1%
$1.52
Last traded 2023-10-13 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $49.3M mcap · 9M float · 24.99% daily turnover

Balance Sheet Trends

Total Assets
$41M +458.3% ▲
5Y CAGR: +122.8%
Total Liabilities
$6M -37.2% ▼
5Y CAGR: +74.8%
Shareholders Equity
$35M +1710.5% ▲
5Y CAGR: +147.2%
Cash & Investments
$2M +478.2% ▲
5Y CAGR: +34.5%
Total Debt
$0 -100.0% ▼
Net Debt
-$2M -870.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2024FY2025
— Assets —
Cash$4M$12M$2M$349K$2M
Short-Term Investments$0$3M$3M$55K$55K
Cash & ST Investments$4M$15M$5M$404K$2M
Net Receivables$255K$695K$648K$284K$90K
Inventory$226K$304K$441K$234K$949K
Other Current Assets$152K$617K$4M$2M$3M
Total Current Assets$5M$16M$7M$3M$6M
Property, Plant & Equip.$36K$906K$706K$394K$85K
Goodwill & Intangibles$2M$2M$1M$4M$15M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$19M
Total Non-Current Assets$2M$3M$2M$5M$35M
Total Assets$7M$19M$9M$7M$41M
— Liabilities —
Accounts Payable$689K$1M$2M$2M$2M
Short-Term Debt$1M$166K$2M$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$112K$161K$367K$7M$6M
Total Current Liabilities$2M$2M$5M$9M$6M
Long-Term Debt$6K$696K$520K$114K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$6K$696K$520K$114K$0
Total Liabilities$2M$2M$5M$10M$6M
— Equity —
Common Stock$11K$24K$22K$2M$3M
Retained Earnings-$7M-$35M-$51M-$115M-$183M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$4M$17M$4M-$2M$35M
Total Liabilities & Equity$7M$19M$9M$7M$41M
— Key Metrics —
Total Debt$1M$862K$3M$114K$0
Net Debt-$3M-$11M$800K-$235K-$2M
Total Investments$0$3M$3M$55K$55K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms